UK Research and Innovation

UK Research and Innovation
Name	UK Research and Innovation
Type	Non-departmental public body
Founded	2018
Headquarters	Polaris House, Swindon
Key people	Sir Andrew Mackenzie (Chair), Professor Dame Ottoline Leyser (CEO)
Industry	Research and development
Parent	Department for Science, Innovation and Technology

UK Research and Innovation is the United Kingdom's primary public body for directing and funding science, research, and innovation. Established in 2018, it operates as a non-departmental public body sponsored by the Department for Science, Innovation and Technology. It brings together seven disciplinary Research Councils, Innovate UK, and the research funding function of Research England into a single strategic organisation.

History and formation

The creation of this body was a central recommendation of the 2015 Nurse Review of Research Councils, led by Sir Paul Nurse. The review argued for greater coordination to address major interdisciplinary challenges and improve economic and societal impact. The organisation was formally established through the Higher Education and Research Act 2017, commencing operations in April 2018. Its formation marked the most significant restructuring of the UK's public research landscape since the early 20th century, consolidating previously separate entities under a single strategic umbrella. This move was influenced by similar models internationally, such as the National Science Foundation in the United States and the Australian Research Council.

Structure and organisation

The organisation is structured around nine constituent bodies, each with distinct mandates. These include the seven legacy Research Councils: the Arts and Humanities Research Council, the Biotechnology and Biological Sciences Research Council, the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, the Medical Research Council, the Natural Environment Research Council, and the Science and Technology Facilities Council. The other two core parts are Innovate UK, which focuses on business-led innovation, and Research England, which funds and regulates higher education research and knowledge exchange. The headquarters are located at Polaris House in Swindon, with additional offices across the United Kingdom, including in London and Cardiff.

Funding and strategic priorities

It allocates an annual budget of over £8 billion, primarily from the government's Department for Science, Innovation and Technology. Strategic priorities are set through multi-year delivery plans, aligning with government objectives such as the Innovation Strategy and Plan for Growth. Major cross-cutting themes include achieving net zero, advancing artificial intelligence and quantum technologies, and improving national health security. A significant portion of funding is directed through core grants to institutions like the University of Oxford, the University of Cambridge, and the Francis Crick Institute, as well as responsive-mode grants for individual investigator-led projects.

Key programmes and initiatives

It manages several large-scale, strategic programmes. These include the UKRI Interdisciplinary Research Hubs, the Industrial Strategy Challenge Fund, and the Strength in Places Fund. It is also the primary UK funder for participation in major international projects such as CERN, the European Space Agency, and the Square Kilometre Array Observatory. Other notable initiatives are the Future Leaders Fellowships, designed to nurture early-career researchers, and the Strategic Priorities Fund, which addresses complex national priorities. During the COVID-19 pandemic, it rapidly funded critical research through the UK Coronavirus Immunology Consortium and the RECOVERY Trial.

Governance and leadership

The organisation is governed by a board appointed by the Secretary of State for Science, Innovation and Technology. The inaugural Chair was Sir John Kingman, succeeded by Sir Andrew Mackenzie. The Chief Executive is Professor Dame Ottoline Leyser, formerly Director of the Sainsbury Laboratory at the University of Cambridge. The board includes senior representatives from academia, industry, and the public sector, such as Professor Sir Mark Walport and Dame Nancy Rothwell. It is accountable to Parliament through its sponsoring department and is scrutinised by committees including the House of Commons Science and Technology Select Committee.

Impact and criticism

Its work supports the UK's position as a leading research nation, with institutions like the University of Oxford and Imperial College London consistently high in global rankings. It plays a pivotal role in major achievements, from the development of the Oxford–AstraZeneca COVID-19 vaccine to breakthroughs at the Rosalind Franklin Institute. However, it has faced criticism from some quarters, including concerns from the Russell Group about the balance of funding between established institutions and newer universities, and debates over research concentration. It has also been scrutinised for its administrative processes and the complexity of its funding landscape, with reviews conducted by bodies like the National Audit Office.

Category:Research organisations in the United Kingdom Category:Science and technology in the United Kingdom Category:Government agencies established in 2018